Literature DB >> 18538440

Tumor-specific marker genes for intrahepatic cholangiocarcinoma: utility and mechanistic insight.

Boris Blechacz, Gregory J Gores.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18538440      PMCID： PMC2885696          DOI： 10.1016/j.jhep.2008.05.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  17 in total

1.  Liver cancer: An evolving challenge reaching research maturity.

Authors:  Jordi Bruix
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

2.  The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.

Authors:  T Maeda; K Kajiyama; E Adachi; K Takenaka; K Sugimachi; M Tsuneyoshi
Journal:  Mod Pathol       Date:  1996-09       Impact factor: 7.842

3.  An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.

Authors:  M Tsuji; T Kashihara; N Terada; H Mori
Journal:  Pathol Int       Date:  1999-04       Impact factor: 2.534

4.  Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours.

Authors:  Y Soini
Journal:  Histopathology       Date:  2005-05       Impact factor: 5.087

5.  Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis.

Authors:  A Rullier; B Le Bail; R Fawaz; J F Blanc; J Saric; P Bioulac-Sage
Journal:  Am J Surg Pathol       Date:  2000-06       Impact factor: 6.394

Review 6.  Claudin proteins in human cancer: promising new targets for diagnosis and therapy.

Authors:  Patrice J Morin
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.

Authors:  Munetoshi Tsukahara; Hideo Nagai; Tomoko Kamiakito; Hirotoshi Kawata; Norio Takayashiki; Ken Saito; Akira Tanaka
Journal:  Pathol Int       Date:  2005-02       Impact factor: 2.534

8.  Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma.

Authors:  Gábor Sobel; Csilla Páska; István Szabó; András Kiss; Anna Kádár; Zsuzsa Schaff
Journal:  Hum Pathol       Date:  2005-02       Impact factor: 3.466

9.  Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.

Authors:  Sean K Lau; Sonam Prakash; Stephen A Geller; Randa Alsabeh
Journal:  Hum Pathol       Date:  2002-12       Impact factor: 3.466

10.  Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium.

Authors:  Miklós Gulyás; Anders Hjerpe
Journal:  J Pathol       Date:  2003-04       Impact factor: 7.996
View more
  7 in total

1.  Markers of bile duct tumors.

Authors:  Giulia Malaguarnera; Maria Giordano; Isabella Paladina; Alessandra Rando; Mario Uccello; Francesco Basile; Antonio Biondi; Santo Carnazzo; Innocenza Alessandria; Clorinda Mazzarino
Journal:  World J Gastrointest Oncol       Date:  2011-04-15

2.  Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.

Authors:  Giammarco Fava; Sharon Demorrow; Eugenio Gaudio; Antonio Franchitto; Paolo Onori; Guido Carpino; Shannon Glaser; Heather Francis; Monique Coufal; Luca Marucci; Domenico Alvaro; Marco Marzioni; Trenton Horst; Romina Mancinelli; Antonio Benedetti; Gianfranco Alpini
Journal:  Liver Int       Date:  2009-03-09       Impact factor: 5.828

3.  Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers.

Authors:  Zsuzsanna Németh; Attila Marcell Szász; Péter Tátrai; Júlia Németh; Hajnalka Gyorffy; Aron Somorácz; Attila Szíjártó; Péter Kupcsulik; András Kiss; Zsuzsa Schaff
Journal:  J Histochem Cytochem       Date:  2008-10-14       Impact factor: 2.479

4.  Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma.

Authors:  Monique Coufal; Pietro Invernizzi; Eugenio Gaudio; Francesca Bernuzzi; Gabriel A Frampton; Paolo Onori; Antonio Franchitto; Guido Carpino; Jonathan C Ramirez; Domenico Alvaro; Marco Marzioni; Guido Battisti; Antonio Benedetti; Sharon DeMorrow
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

5.  Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents.

Authors:  Gabriel A Frampton; Eric A Lazcano; Huang Li; Akimuddin Mohamad; Sharon DeMorrow
Journal:  Lab Invest       Date:  2010-05-10       Impact factor: 5.662

6.  Long Non-Coding RNA-PAICC Promotes the Tumorigenesis of Human Intrahepatic Cholangiocarcinoma by Increasing YAP1 Transcription.

Authors:  Long Xia; Xiaolong Chen; Jiarui Yang; Shuguang Zhu; Lei Zhang; Qi Yin; Yueyu Hong; Haoqi Chen; Guihua Chen; Hua Li
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

Review 7.  New insights on the role of vascular endothelial growth factor in biliary pathophysiology.

Authors:  Valeria Mariotti; Romina Fiorotto; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  JHEP Rep       Date:  2021-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.